Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Leukemia, Myeloid, Acute × Daunorubicin × Clear all

Phase

Status

Completed 61 Recruiting 23 Active not recruiting 17 Terminated 12 Unknown 10 Not yet recruiting 7 Withdrawn 4 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 2 venetoclax 1 ibrutinib 1 fludarabine phosphate 1 fludarabine 1 decitabine and cedazuridine drug combination 1 Melphalan 1 JNJ-64619178 1 JNJ-64264681 1 Inosine Monophosphate 1 Dexamethasone 1 Daunorubicin 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06697327 2025-05-14

Daunorubicin + Cytarabine + Venetoclax in de Novo AML

Anhui Medical University

Phase NA Enrolling by invitation

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡